(Q42631739)

4 November 2017

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis (English)

1 reference

4 November 2017

0 references

1 reference

1 reference

Kroot EJ

1

1 reference

4 November 2017

de Jong BA

2

1 reference

4 November 2017

van Leeuwen MA

3

1 reference

4 November 2017

Swinkels H

4

1 reference

4 November 2017

van den Hoogen FH

5

1 reference

4 November 2017

van't Hof M

6

1 reference

4 November 2017

van de Putte LB

7

1 reference

4 November 2017

van Rijswijk MH

8

1 reference

4 November 2017

van Venrooij WJ

9

1 reference

4 November 2017

van Riel PL

10

1 reference

4 November 2017

1 August 2000

1 reference

4 November 2017

Arthritis & Rheumatology

1 reference

4 November 2017

43

1 reference

4 November 2017

8

1 reference

4 November 2017

1831-1835

1 reference

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

4 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

Measurement of patient outcome in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

Can we predict aggressive disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200008%2943%3A8%3C1831%3A%3AAID-ANR19%3E3.0.CO%3B2-6

10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference